MedPath

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Phase 2
Suspended
Conditions
HIV Infections
Registration Number
NCT00002424
Lead Sponsor
Merck Sharp & Dohme LLC
Brief Summary

This study will see how safe and effective against HIV the drugs L-756423 plus indinavir (IDV) are compared to just IDV when taken with stavudine (d4T) and lamivudine (3TC). The study will also see whether taking 1 large dose of L-756423/IDV once a day is as safe and effective as taking 2 smaller doses twice a day.

Detailed Description

Patients are randomized to 1 of 4 treatment arms. In Group 1, patients receive a dose of L-756423/IDV once daily plus IDV placebo. In Group 3, patients receive a lower dose of L-756423/IDV twice daily (with the daily dosage equaling that of Group 1) plus IDV placebo. In Groups 2 and 4, patients receive equal dosages of IDV plus L-756423/IDV placebo. In all 4 groups L-756423 and IDV are blinded to the investigator and patient. All groups receive open-label d4T and 3TC. Patients routinely undergo a physical exam and have blood and urine tests to ensure the drugs' safety and tolerability, which will be evaluated by tabulation of adverse events and clinical assessment of laboratory data. In addition, CD4+ T cell and plasma viral RNA levels are measured to quantify the drugs' antiretroviral activity.

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
186
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (16)

UCLA School of Medicine / Ctr for Research and Education

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Georgetown Univ Med Ctr

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

ViRx / Dupont Circle Physicians Group

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Associates in Research

πŸ‡ΊπŸ‡Έ

Fort Myers, Florida, United States

Univ of Miami School of Medicine

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Grady Mem Hosp

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Rush Presbyterian - Saint Luke's Med Ctr

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

The CORE Ctr

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Univ of Kentucky Med Ctr

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

Univ of Kentucky

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

Scroll for more (6 remaining)
UCLA School of Medicine / Ctr for Research and Education
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.